Monday, May 15, 2017 3:10:00 PM
I believe the early technology going back ten years was legacy technology and subsequently found to be valueless, and the two later technologies invented by the CEO were a major change of direction for the company which will enrich all of us who are shareholders.
The petri flat packaging should have good appeal to markets worldwide, and the N-Assay should also have very broad appeal around the world.
As for a ten year period being cited as indicative of lack of management capabilities, I must opine that for them to have spent much time on development of the legacy technologies would have meant that any of you who were invested from 2007 and through the subsequent years until the undoubted end of Nanologix would have meant that you would have lost everything and I and others who came later would have never invested because there wouldn't have been a company to invest in.
So I view management as far from lacking.
Most of this comes from information I have gleaned through due diligence and in my quest to update this website.
EI
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM